✦ LIBER ✦

Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens

✍ Scribed by N. Baize; A. Abakar-Mahamat; N. Mounier; F. Berthier; F. X. Caroli-Bosc

Publisher: Springer
Year: 2009
Tongue: English
Weight: 276 KB
Volume: 64
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0903-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of patients with advanced gast

Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen : Two parallel randomized phase II studies

✍ Carlo Barone; Domenico C. Corsi; Carmelo Pozzo; Alessandra Cassano; Tecla Fontan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

370 mg/m 2 , on Days 1-5 and 36 others in Study B received epirubicin, 30 mg/m 2 , cina Interna e Geriatria, Universita `Cattolica del on Days 1 and 5; etoposide, 100 mg/m 2 , on Days 1, 3, and 5; cisplatin, 30 mg/m 2 , S. Cuore, Rome, Italy. on Days 2 and 4; and lonidamine, 150 mg/day. ## RESULTS

Phase I/II study of a combination of doc

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer

✍ Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung-Moon Chang; Jeong Hwan Yook; Su 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 334 KB

Phase II study of weekly chemotherapy wi

Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 330 KB